Effects of Imidapril, an Angiotensin-converting Enzyme Inhibitor, on Insulin Sensitivity and Responsiveness in Streptozotocin-induced Diabetic Rats

Hormone and Metabolic Research

Volumn 36, Issue 1, 2004, Pages 34-38

  Viana, A Y I ^a   Oshida, Y ^a,b   Han, Y Q ^b   Koshinaka, K ^a   Sato, Y ^a,b  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

Author keywords

Angiotensin Converting Enzyme Inhibitor; Euglycemic Clamp Technique; L NMMA; Streptozotocin

Indexed keywords

IMIDAPRIL; N(G) METHYLARGININE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES INSIPIDUS; DRUG EFFECT; DRUG MECHANISM; GLUCOSE BLOOD LEVEL; GLUCOSE INFUSION; INSULIN BLOOD LEVEL; INSULIN INFUSION; INSULIN SENSITIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; STREPTOZOCIN DIABETES;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; IMIDAZOLES; IMIDAZOLIDINES; INSULIN; INSULIN RESISTANCE; MALE; NITRIC OXIDE SYNTHASE; OMEGA-N-METHYLARGININE; RATS; RATS, WISTAR;

ANIMALIA;

EID: 1442314810     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-814100     Document Type: Article

References (24)

1. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S. Insulin resistance in essential hypertension. N Engl J Med 1987; 317: 350-357
2. Luzio SD, Dunseath G, Owens DR. Acute effects of valsartan on insulin sensitivity in obese, non-hypertensive subjects with and without type 2 diabetes. Horm Metab Res 2002; 34: 271-274
3. Erdös E. Angiotensin I converting enzyme. Circ Res 1975; 36: 247-255
4. Uehara M, Nishikawa H, Isami S, Kisanuki K, Ohkubo Y, Miyamura N, Miyata T, Yano T, Shichiri M. Effect on insulin sensitivity of angiotensin converting enzyme inhibitors with or without a sulphydryl group: Bradykinin may improve insulin resistance in dogs and humans. Diabetologia 1994; 37: 300-307
5. Nawano M, Anai M, Funaki M, Kobayashi H, Kanda A, Fukushima Y, Inukai K, Ogihara T, Sakoda H, Onishi Y, Kikuchi M, Yazaki Y, Oka Y, Asano T. Imidapril, an angiotensin-converting enzyme inhibitor, improves insulin sensitivity by enhancing signal transduction via insulin receptor substrate proteins and improving vascular resistance in the Zucker fatty rat. Metabolism 1999; 48: 1248-1255
6. Carvalho CRO, Thirone ACP, Gontijo JAR, Velloso LA, Saad MJA. Effect of captopril, losartan, and bradykinin on early steps of insulin action. Diabetes 1997; 46: 1950-1957
7. Miyata T, Taguchi T, Uehara M, Isami S, Kishikawa H, Kaneko K, Araki E, Shirichi M. Bradykinin potentiates insulin-stimulated glucose uptake and enhances insulin signal through the bradykinin B2 receptor in dog skeletal muscle and rat L6 myoblasts. Eur J Endocrinol 1998; 138: 344-352
8. Hendriksen EJ, Jacob S. Effects of captopril on glucose transport activity in skeletal muscle of obese Zucker rats. Metabolism 1995; 44: 267-272
9. American Diabetes Association. Treatment of hypertension in adults with diabetes (Position Statement). Diabetes Care 2002; 25 (S1): S71-S73
10. Fujiwara T, Yuasa H, Ogiku N, Kawai Y. Histopathological investigation on salt-loaded stroke-prone spontaneously hypertensive rats, whose biochemical parameters of renal dysfunction were ameliorated by administration of imidapril. Jpn J Pharmacol 1994; 66: 231-240
11. Kadowaki T, Kasuga M, Akanuma Y, Ezaki O, Takaku F. Decreased autophosphorylation of the insulin receptor-kinase in streptozotocin-diabetic rats. J Biol Chem 1984; 259: 14208-14216
12. Mitchell D, Tyml K. Nitric oxide release in rat skeletal muscle capillary. Am J Physiol 1996; 270: H1696-H1703
13. Higaki Y, Hirshman MF, Fujii N, Goodyear LJ. Nitric oxide increases glucose uptake through a mechanism that is distinct from the insulin and contraction pathways in rat skeletal muscle. Diabetes 2001; 50: 241-247
14. Roy D, Perreault M, Marette A. Insulin stimulation of glucose uptake in skeletal muscles and adipose tissues in vivo is NO dependent. Am J Physiol 1998; 274: E692-E699
15. Oshida Y, Tachi Y, Morishita Y, Kitakoshi K, Fuku N, Han YQ, Ohsawa I and Sato Y. Nitric oxide decreases insulin resistance induced by high-fructose feeding. Horm Metab Res 2000; 32: 339-342
16. Li L, Oshida Y, Kusunoki M, Yamanouchi K, Johansson BL, Wahren J, Sato Y. Rat C peptide I and II stimulate glucose utilization in STZ-induced diabetic rats. Diabetologia 1999; 42: 958-964
17. Oshida Y, Kako M, Nakai N, Shimomura Y, Li L, Sato J, Ohsawa I, Sato Y. Troglitazone improves insulin-stimulated glucose utilization associated with an increased muscle glycogen content in obese Zucker rats. Endocr J 1999; 46: 723-730
18. Kawashima H, Igarashi T, Nakajima Y, Akiyama Y, Usuki K, Ohta S. Chronic hypertension induced by streptozotocin rats. Naunyn Schmiedebergs Arch Pharmacol 1978; 305: 123-126
19. Hartmann JF, Szemplinski M, Hayes NS, Keegan ME, Slater EE. Effects of the angiotensin converting enzyme inhibitor, lisinopril, on normal and diabetic rats. J Hypertens 1988; 6: 677-683
20. Jacob S, Hendriksen EJ, Fogt DL, Dietze GJ. Effects of trandolapril and verapamil on glucose transport in insulin-resistant rat skeletal muscle. Metabolism 1996; 45: 535-541
21. Jauch KW, Hartl W, Günther B, Wicklmayr M, Rett K, Dietze G. Captopril enhances insulin responsiveness of forearm muscle tissue in non-insulin dependent diabetes mellitus. Eur J Clin Invest 1987; 17: 448-454
22. Kahn CR. Insulin resistance, insulin insensitivity, and insulin unresponsiveness: a necessary distinction. Metabolism 1978; 27: 1893-1902
23. Olefsky JM, Kolterman OG, Scarlett JA. Insulin action and resistance in obesity and noninsulin-dependent type II diabetes mellitus. Am J Physiol 1982; 243: E15-30
24. Balon TW, Nadler JL. Nitric oxide is present from incubated skeletal muscle. J Appl Physiol 1994; 77: 2519-2521